RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.22B
AUM Growth
+$986M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
109
New
Increased
Reduced
Closed

Top Buys

1
+$272M
2
+$226M
3
+$198M
4
ICVX
Icosavax, Inc. Common Stock
ICVX
+$196M
5
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$177M

Top Sells

1
+$112M
2
+$102M
3
+$57.6M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$56.4M
5
TRIL
Trillium Therapeutics Inc.
TRIL
+$51.3M

Sector Composition

1 Healthcare 99.06%
2 Financials 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-255,277
102
– –
-584,000
103
– –
-156,250
104
– –
-2,200,000
105
– –
-1,000,000
106
– –
-5,290,481
107
– –
-233,333
108
– –
-6,077,294
109
– –
-15,000
1 2 3 4
5